Welcome!

News Feed Item

Cardiac Arrest Global Clinical Trials Review, H1, 2014

NEW YORK, Feb. 12, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Cardiac Arrest Global Clinical Trials Review, H1, 2014
http://www.reportlinker.com/p0869179/Cardiac-Arrest-Global-Clinical-Trials-Review-H1-2014.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

Cardiac Arrest Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, "Cardiac Arrest Global Clinical Trials Review, H1, 2014" provides data on the Cardiac Arrest clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cardiac Arrest. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cardiac Arrest. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Cardiac Arrest 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Cardiac Arrest to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Cardiac Arrest to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Cardiac Arrest 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Cardiac Arrest Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Cardiac Arrest 33
Nov 07, 2012: Metformin Offers Cardio Benefits Over Sulfonylureas In Diabetes, Study Finds 33
Aug 22, 2012: NIH Launches Trial To Evaluate Anti-inflammatory Treatment For Preventing Heart Attacks, Strokes, And Cardiovascular Deaths 33
Aug 22, 2012: Brigham And Women's Hospital Researchers Initiate Major Cardiovascular Inflammation Reduction Trial Using Teva's Trexall 34
Mar 25, 2012: Infusion Of Abciximab Into Coronary Artery May Reduce Size Of Heart Damage After Heart Attack 35
Nov 13, 2011: Anti-Clotting Drug Lowers Risks In Acute Coronary Syndrome Treatment 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
Janssen Global Services, LLC 37
Clinical Trial Overview of Janssen Global Services, LLC 37
Boston Scientific Corporation 38
Clinical Trial Overview of Boston Scientific Corporation 38
Biotronik SE & Co. KG 39
Clinical Trial Overview of Biotronik SE & Co. KG 39
PT Dexa Medica 40
Clinical Trial Overview of PT Dexa Medica 40
Johnson & Johnson 41
Clinical Trial Overview of Johnson & Johnson 41
Janssen-Cilag A.G. 42
Clinical Trial Overview of Janssen-Cilag A.G. 42
C. H. Boehringer Sohn AG & Co. KG 43
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 43
Clinical Trial Overview of Top Institutes / Government 44
Ottawa Hospital Research Institute 44
Clinical Trial Overview of Ottawa Hospital Research Institute 44
University of Washington 45
Clinical Trial Overview of University of Washington 45
National Heart, Lung, and Blood Institute 46
Clinical Trial Overview of National Heart, Lung, and Blood Institute 46
Kyoto University 47
Clinical Trial Overview of Kyoto University 47
Medical University of Vienna 48
Clinical Trial Overview of Medical University of Vienna 48
University of Pennsylvania 49
Clinical Trial Overview of University of Pennsylvania 49
Sunnybrook Health Sciences Centre 50
Clinical Trial Overview of Sunnybrook Health Sciences Centre 50
Assistance Publique - Hopitaux de Paris 51
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 51
University Hospital Basel 52
Clinical Trial Overview of University Hospital Basel 52
National Taiwan University Hospital 53
Clinical Trial Overview of National Taiwan University Hospital 53
Five Key Clinical Profiles 54
Appendix 74
Abbreviations 74
Definitions 74
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 78

List of Tables

Cardiac Arrest Therapeutics, Global, Clinical Trials by Region, 2014* 7
Cardiac Arrest Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Cardiac Arrest Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Cardiac Arrest Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Cardiac Arrest Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Cardiac Arrest Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Cardiac Arrest Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Cardiac Arrest Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Cardiac Arrest to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Cardiac Arrest Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Cardiac Arrest Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Cardiac Arrest to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Cardiac Arrest Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Cardiac Arrest Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Cardiac Arrest Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Cardiac Arrest Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Cardiac Arrest Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Cardiac Arrest Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Cardiac Arrest Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Cardiac Arrest Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Cardiac Arrest Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Cardiac Arrest Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Cardiac Arrest Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Cardiac Arrest Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Cardiac Arrest Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Global Services, LLC, 2014* 37
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Scientific Corporation, 2014* 38
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Biotronik SE & Co. KG, 2014* 39
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by PT Dexa Medica, 2014* 40
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 41
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen-Cilag A.G., 2014* 42
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014* 43
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2014* 44
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 45
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 46
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2014* 47
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014* 48
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014* 49
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Sunnybrook Health Sciences Centre, 2014* 50
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 51
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014* 52
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 53

List of Figures

Cardiac Arrest Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Cardiac Arrest Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Cardiac Arrest Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Cardiac Arrest Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Cardiac Arrest Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Cardiac Arrest Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Cardiac Arrest Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Cardiac Arrest to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Cardiac Arrest Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Cardiac Arrest Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Cardiac Arrest to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Cardiac Arrest Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Cardiac Arrest Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Cardiac Arrest Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Cardiac Arrest Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Cardiac Arrest Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Cardiac Arrest Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Cardiac Arrest Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Cardiac Arrest Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Cardiac Arrest Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Cardiac Arrest Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 76

To order this report: Cardiac Arrest Global Clinical Trials Review, H1, 2014
http://www.reportlinker.com/p0869179/Cardiac-Arrest-Global-Clinical-Trials-Review-H1-2014.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Cloud computing is being adopted in one form or another by 94% of enterprises today. Tens of billions of new devices are being connected to The Internet of Things. And Big Data is driving this bus. An exponential increase is expected in the amount of information being processed, managed, analyzed, and acted upon by enterprise IT. This amazing is not part of some distant future - it is happening today. One report shows a 650% increase in enterprise data by 2020. Other estimates are even higher....
From wearable activity trackers to fantasy e-sports, data and technology are transforming the way athletes train for the game and fans engage with their teams. In his session at @ThingsExpo, will present key data findings from leading sports organizations San Francisco 49ers, Orlando Magic NBA team. By utilizing data analytics these sports orgs have recognized new revenue streams, doubled its fan base and streamlined costs at its stadiums. John Paul is the CEO and Founder of VenueNext. Prior ...
One of biggest questions about Big Data is “How do we harness all that information for business use quickly and effectively?” Geographic Information Systems (GIS) or spatial technology is about more than making maps, but adding critical context and meaning to data of all types, coming from all different channels – even sensors. In his session at @ThingsExpo, William (Bill) Meehan, director of utility solutions for Esri, will take a closer look at the current state of spatial technology and ar...
The Internet of Things can drive efficiency for airlines and airports. In their session at @ThingsExpo, Shyam Varan Nath, Principal Architect with GE, and Sudip Majumder, senior director of development at Oracle, will discuss the technical details of the connected airline baggage and related social media solutions. These IoT applications will enhance travelers' journey experience and drive efficiency for the airlines and the airports. The session will include a working demo and a technical d...
What happens when the different parts of a vehicle become smarter than the vehicle itself? As we move toward the era of smart everything, hundreds of entities in a vehicle that communicate with each other, the vehicle and external systems create a need for identity orchestration so that all entities work as a conglomerate. Much like an orchestra without a conductor, without the ability to secure, control, and connect the link between a vehicle’s head unit, devices, and systems and to manage the ...
Businesses are struggling to manage the information flow and interactions between all of these new devices and things jumping on their network, and the apps and IT systems they control. The data businesses gather is only helpful if they can do something with it. In his session at @ThingsExpo, Chris Witeck, Principal Technology Strategist at Citrix, will discuss how different the impact of IoT will be for large businesses, expanding how IoT will allow large organizations to make their legacy ap...
The many IoT deployments around the world are busy integrating smart devices and sensors into their enterprise IT infrastructures. Yet all of this technology – and there are an amazing number of choices – is of no use without the software to gather, communicate, and analyze the new data flows. Without software, there is no IT. In this power panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, panelists will look at the protocols that communicate data and the emerging data analy...
As ridesharing competitors and enhanced services increase, notable changes are occurring in the transportation model. Despite the cost-effective means and flexibility of ridesharing, both drivers and users will need to be aware of the connected environment and how it will impact the ridesharing experience. In his session at @ThingsExpo, Timothy Evavold, Executive Director Automotive at Covisint, will discuss key challenges and solutions to powering a ride sharing and/or multimodal model in the a...
SYS-CON Events announced today that Commvault, a global leader in enterprise data protection and information management, has been named “Bronze Sponsor” of SYS-CON's 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Commvault is a leading provider of data protection and information management solutions, helping companies worldwide activate their data to drive more value and business insight and to transform moder...
Creating replica copies to tolerate a certain number of failures is easy, but very expensive at cloud-scale. Conventional RAID has lower overhead, but it is limited in the number of failures it can tolerate. And the management is like herding cats (overseeing capacity, rebuilds, migrations, and degraded performance). Download Slide Deck: ▸ Here In his general session at 18th Cloud Expo, Scott Cleland, Senior Director of Product Marketing for the HGST Cloud Infrastructure Business Unit, discusse...
Whether they’re located in a public, private, or hybrid cloud environment, cloud technologies are constantly evolving. While the innovation is exciting, the end mission of delivering business value and rapidly producing incremental product features is paramount. In his session at @DevOpsSummit at 19th Cloud Expo, Kiran Chitturi, CTO Architect at Sungard AS, will discuss DevOps culture, its evolution of frameworks and technologies, and how it is achieving maturity. He will also cover various st...
SYS-CON Events announced today that eCube Systems, a leading provider of middleware modernization, integration, and management solutions, will exhibit at @DevOpsSummit at 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. eCube Systems offers a family of middleware evolution products and services that maximize return on technology investment by leveraging existing technical equity to meet evolving business needs. ...
All clouds are not equal. To succeed in a DevOps context, organizations should plan to develop/deploy apps across a choice of on-premise and public clouds simultaneously depending on the business needs. This is where the concept of the Lean Cloud comes in - resting on the idea that you often need to relocate your app modules over their life cycles for both innovation and operational efficiency in the cloud. In his session at @DevOpsSummit at19th Cloud Expo, Valentin (Val) Bercovici, CTO of So...
What are the new priorities for the connected business? First: businesses need to think differently about the types of connections they will need to make – these span well beyond the traditional app to app into more modern forms of integration including SaaS integrations, mobile integrations, APIs, device integration and Big Data integration. It’s important these are unified together vs. doing them all piecemeal. Second, these types of connections need to be simple to design, adapt and configure...
Digital innovation is the next big wave of business transformation based on digital technologies of which IoT and Big Data are key components, For example: Business boundary innovation is a challenge to excavate third-party business value using IoT and BigData, like Nest Business structure innovation may propose re-building business structure from scratch, as Uber does in the taxicab industry The social model innovation is also a big challenge to the new social architecture with the design fr...